TBA (last known deadline was January 7, 2010)
New approaches in brain tumor research are emerging, generated by the use of new genetic tools, insights from neurogenesis and stem cell biology, and the availability of novel molecules as potential chemotherapeutic interventions. The Goldhirsh Foundation is interested in providing strategic investment in both pediatric and adult brain tumor research to accelerate progress toward more effective treatment for malignant diffuse glioma tumors. Applications are encouraged from investigators working in the continuum between basic research and clinical application, integrating and translating knowledge in various disciplines into meaningful progress for patients. Examples of funding areas include but are not limited to oncogenomics and proteomics, genetically engineered models, the discovery and testing of small molecule therapies, unusual drug delivery systems, or improved brain imaging techniques. Research projects at the interface of developmental biology and cancer along the stem cell to glial axis are eligible.